 VolitionRx NYSE-A:VNRX Limited announced it had presented data about its work on neutrophil extracellular traps, or NETs, at the International Society on Thrombosis and Haemostasis ISTH Congress. The firm, in collaboration with researchers at the University of Namur and QUALIblood in Belgium, published a poster presentation entitled Evaluation and comparison of NETosis biomarkers in sepsis and COVID-19 patients at the conference. 